Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Alset EHome International | AEI | 2. jan 2025 | 1.38 | +35.29 |
Alt5 Sigma | ALTS | 2. jan 2025 | 5.15 | +10.75 |
Alta Equipment A Pref | ALTG-A | 2. jan 2025 | 25.70 | +0.39 |
Alta Equipment Group A | ALTG | 2. jan 2025 | 6.55 | +0.15 |
Altair Engineering A | ALTR | 2. jan 2025 | 109.31 | +0.18 |
Altamira Therapeutics | CYTO | 2. jan 2025 | 0.41 | 0.00 |
AltEnergy Acquisition A | AEAE | 2. jan 2025 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | 2. jan 2025 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | 2. jan 2025 | 3.73 | +12.69 |
Alternus Clean Energy A | ALCE | 2. jan 2025 | 1.00 | +27.23 |
Alti Global A | ALTI | 2. jan 2025 | 4.39 | -0.45 |
Altice USA A | ATUS | 2. jan 2025 | 2.37 | -1.66 |
Altimmune | ALT | 2. jan 2025 | 7.11 | -1.39 |
Altisource Portfolio Solutions | ASPS | 2. jan 2025 | 0.68 | +3.24 |
Alto Ingredients | ALTO | 2. jan 2025 | 1.69 | +8.33 |
Alto Neuroscience | ANRO | 2. jan 2025 | 4.38 | +3.55 |
Altria Group | MO | 2. jan 2025 | 52.51 | +0.42 |
Altus Power A | AMPS | 2. jan 2025 | 4.26 | +4.67 |
Alumis | ALMS | 2. jan 2025 | 8.22 | +4.58 |
Alvotech | ALVO | 2. jan 2025 | 13.16 | -0.53 |
ALX Oncology | ALXO | 2. jan 2025 | 1.56 | -6.59 |
Alzamend Neuro | ALZN | 2. jan 2025 | 1.20 | +3.45 |
Amalgamated Financial | AMAL | 2. jan 2025 | 33.17 | -0.90 |
Amarin ADR | AMRN | 2. jan 2025 | 0.52 | +7.96 |
Amazon.com | AMZN | 2. jan 2025 | 220.22 | +0.38 |
Ambac Financial Group | AMBC | 2. jan 2025 | 12.41 | -1.90 |
Ambarella | AMBA | 2. jan 2025 | 74.10 | +1.87 |
Ambev ADR | ABEV | 2. jan 2025 | 1.83 | -1.08 |
Ambipar Emergency Response | AMBI | 2. jan 2025 | 5.35 | +1.13 |
Ambow Education A ADR | AMBO | 2. jan 2025 | 3.05 | +45.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.